MYC and colorectal cancer: To investigate the epigenetic regulation of MYC-AS1 in colorectal cancer and its functional consequences on oncogene activation, we examined the DNA methylation status of MYC-AS1 in clinical tissues and evaluated whether demethylation therapy (5-Aza-CdR) could restore its expression to suppress c-MYC-driven oncogenicity.